Orapred ODT Articles
Mylan in patent settlement with Shionogi over Orapred ODT
11 October 2012
Mylan sued by Shionogi and CIMA over Orapred patent challenge
20 December 2010
BioMarin's 2nd-qtr 2007 loss widens to $3.9M
20 August 2007
BioMarin and Alliant sign Orapred deal
27 March 2006
BioMarin submist NDA to US FDA for ODT prednisolone
8 August 2005
Showing 1-5 of 5 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
